Supposedly, prostaglandin analogs (PGA) could reduce the central corneal thickness (CCT), while topical carbonic anhydrase inhibitors (TCAI) could increase CCT. The aim of the study was to evaluate clinically significant CCT effects in patients treated with PGA or TCAI
Purpose: To evaluate whether prostaglandin (PG) analogue use is associated with alterations in kerat...
Purpose: To evaluate the effect of topical antiglaucomatous medications on central corneal epithelia...
The aims of the following study were to compare the efficacy of Dorzolamide 1% eye drops with system...
Supposedly, prostaglandin analogs (PGA) could reduce the central corneal thickness (CCT), while topi...
Purpose: Supposedly, prostaglandin analogs (PGA) could reduce the central corneal thickness (CCT), w...
PURPOSE: Supposedly, prostaglandin analogs (PGA) could reduce the central corneal thickness (CCT...
Purpose: Supposedly, prostaglandin analogs (PGA) could reduce the central corneal thickness (CCT), w...
To investigate whether prostaglandin analogue (PGA) eyedrops have a significant effect on central co...
Objective: The aim of this study was to verify the influence of prostaglandin analogs and prostamide...
Purpose: To evaluate the effect of prostaglandin analogues on the central corneal thickness (CCT) of...
To measure central corneal thickness (CCT) within the participants of the European Glaucoma Preventi...
Purpose: A meta-analysis of observational studies was conducted to evaluate the effect of prostaglan...
Panagiotis Tsikripis, Dimitrios Papaconstantinou, Chryssanthi Koutsandrea, Michalis Apostolopoulos, ...
CILJEVI ISTRAŽIVANJA: Ciljevi istraživanja bili su ispitati postoji li razlika u centralnoj debljini...
Background: To determine the change in central corneal thickness over time and whether the use of lo...
Purpose: To evaluate whether prostaglandin (PG) analogue use is associated with alterations in kerat...
Purpose: To evaluate the effect of topical antiglaucomatous medications on central corneal epithelia...
The aims of the following study were to compare the efficacy of Dorzolamide 1% eye drops with system...
Supposedly, prostaglandin analogs (PGA) could reduce the central corneal thickness (CCT), while topi...
Purpose: Supposedly, prostaglandin analogs (PGA) could reduce the central corneal thickness (CCT), w...
PURPOSE: Supposedly, prostaglandin analogs (PGA) could reduce the central corneal thickness (CCT...
Purpose: Supposedly, prostaglandin analogs (PGA) could reduce the central corneal thickness (CCT), w...
To investigate whether prostaglandin analogue (PGA) eyedrops have a significant effect on central co...
Objective: The aim of this study was to verify the influence of prostaglandin analogs and prostamide...
Purpose: To evaluate the effect of prostaglandin analogues on the central corneal thickness (CCT) of...
To measure central corneal thickness (CCT) within the participants of the European Glaucoma Preventi...
Purpose: A meta-analysis of observational studies was conducted to evaluate the effect of prostaglan...
Panagiotis Tsikripis, Dimitrios Papaconstantinou, Chryssanthi Koutsandrea, Michalis Apostolopoulos, ...
CILJEVI ISTRAŽIVANJA: Ciljevi istraživanja bili su ispitati postoji li razlika u centralnoj debljini...
Background: To determine the change in central corneal thickness over time and whether the use of lo...
Purpose: To evaluate whether prostaglandin (PG) analogue use is associated with alterations in kerat...
Purpose: To evaluate the effect of topical antiglaucomatous medications on central corneal epithelia...
The aims of the following study were to compare the efficacy of Dorzolamide 1% eye drops with system...